CD34 and acute myeloid leukemia: In contrast to AML, donor variant PIP4K2A-1N was not recognized on CD34+ cells, which is probably due to low HLA class II expression or other accessory molecules in these cells since exogenous peptide loading also induced only marginal T-cell recognition of LB-PIP4K2A-1S.